Systemic Lupus Erythematosus (SLE or lupus) is a complex autoimmune disease that is often difficult to manage. An individual’s genomic activity can influence disease progression and response to standard therapy. Lupus research is revealing new drug targets and enabling the development of targeted therapies that ma [...]
Two new lupus therapies target the influential IFN-1 pathway
Better health management begins at home
Subscribe to receive the latest information on new developments and products at DxTerity.